AMERICAN ONCOLOGIC HOSPIAL — History
CCN 390196 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$230M
Latest Revenue (FY2022)
+4.9%
Revenue CAGR (3yr)
-11.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $209M | $220M | $230M | +4.6% | +4.9% |
| Operating Expenses | $232M | $234M | $255M | +9.2% | +4.9% |
| Operating Margin | -11.0% | -6.4% | -11.1% | -74.0% | +0.0% |
| Net Income | $-23M | $-14M | $-26M | -81.9% | +0.0% |
| Licensed Beds | 100 | 100 | 100 | +0.0% | +0.0% |
| Total Patient Days | 18,098 | 19,602 | 21,440 | +9.4% | +8.8% |
| Medicare Day % | 33% | 32% | 31% | -3.6% | -3.4% |
| Medicaid Day % | 3% | 2% | 1% | -59.3% | -40.2% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +10.0% ($209M → $230M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.9%
This Hospital
+7.6%
State Avg
Latest Margin
-11.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $240M | -11.2% |
| FY2024 (proj) | $251M | -11.3% |
| FY2025 (proj) | $261M | -11.4% |